Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified

ICU Medical

(

ICUI

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified ICU Medical as such a stock due to the following factors:

  • ICUI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $16.5 million.
  • ICUI has traded 12,910 shares today.
  • ICUI is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in ICUI with the Ticky from Trade-Ideas. See the FREE profile for ICUI NOW at Trade-Ideas

More details on ICUI:

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. ICUI has a PE ratio of 54. Currently there are 4 analysts that rate ICU Medical a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for ICU Medical has been 123,600 shares per day over the past 30 days. ICU Medical has a market cap of $1.6 billion and is part of the health care sector and health services industry. The stock has a beta of 0.26 and a short float of 7.2% with 7.48 days to cover. Shares are up 21.7% year-to-date as of the close of trading on Friday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates ICU Medical as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from the ratings report include:

  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Health Care Equipment & Supplies industry. The net income increased by 45.5% when compared to the same quarter one year prior, rising from $6.66 million to $9.69 million.
  • ICUI's revenue growth trails the industry average of 29.9%. Since the same quarter one year prior, revenues rose by 11.3%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • ICUI has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 12.08, which clearly demonstrates the ability to cover short-term cash needs.
  • The gross profit margin for ICU MEDICAL INC is rather high; currently it is at 57.86%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 11.88% is above that of the industry average.
  • Net operating cash flow has slightly increased to $13.25 million or 4.22% when compared to the same quarter last year. Despite an increase in cash flow, ICU MEDICAL INC's average is still marginally south of the industry average growth rate of 8.63%.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.